Home

Welcome to ECTRIMS

The European Committee for Treatment and Research in Multiple Sclerosis is a non-profit, independent, representative European-wide organisation that serves as Europe’s and the world’s largest professional organisation dedicated to the understanding and treatment of multiple sclerosis.

Discover your ECTRIMS Fellowship

Our three ECTRIMS fellowships in Clinical Training, Postdoctoral Research, and Nurse & AHP Training are dedicated to helping young MS professionals advance their knowledge & expertise in the field of MS.

> Read more

Read more about the #ECTRIMS2022 early bird special, the start of our 2023 fellowship application season, our latest E-insights, and other news and activities on research and care in multiple sclerosis.

> Read more

E-Insights: MS and Cognition

How does MS affect cognition, and what are the underlying factors? The latest ECTRIMS insights explores the multifaceted factors affecting cognitive impairment, from physical impairment to education levels.

> Read More

Apply for a 2023 ECTRIMS Fellowship

Experience the Evolution: Register for ECTRIMS 2022

Digitally United - Wrapping up ECTRIMS 2021

EAN/ECTRIMS Vaccination Standards for MS patients

ECTRIMS 2021:
Be part of an outstanding digital experience 13-15 October 2021

ECTRIMS Focused Workshop 2021 - Highlights

Stay connected

Find below our Twitter-Feed to get the hottest news.

ECTRIMS @ECTRIMS·

12h

Tip for our 2023 Nurse and #AHP Training Fellowship: #MS professionals from ANY country ... 🌍 with qualifications in nursing, psychology, physiotherapy, etc may apply. Don’t miss your opportunity to be part of this ECTRIMS experience.

Apply today ➡️ https://bit.ly/3l2eu29

ECTRIMS @ECTRIMS·

5 Aug

WARNING: As it unfortunately happens with large events, an increasing number of ... fraudulent websites are impersonating #ECTRIMS2022. We remind participants to be weary of possible scams and to ONLY use the official ECTRIMS 2022 registration website: https://bit.ly/3INsZAm

ECTRIMS @ECTRIMS·

3 Aug

#MSJournal: #MS research from @HopkinsMedicine and @NIHAging suggest that neuronally ... enriched extracellular vesicles (NEVs) could serve as potential biomarkers of disease progression & provide the rationale for larger follow-up longitudinal studies

➡️ https://bit.ly/3JpdPn5

ECTRIMS @ECTRIMS·

2 Aug

Our 2023 Clinical Training #Fellowships provide young #Neurologists & other ... physicians the opportunity to learn the latest techniques in patient management & care and to foster their careers as #MS physicians.

Get started on your application today ➡️ https://bit.ly/3NrrIl7

ECTRIMS @ECTRIMS·

2 Aug

Over the last 2 years we’ve listened & learnt how and where we can evolve to ... better meet the needs of our #MS research community & continue delivering our mission. ECTRIMS has evolved, and so has our congress

Join us this Oct to experience #ECTRIMS2022 ➡️ https://bit.ly/3uw29rG

ECTRIMS @ECTRIMS·

1 Aug

#MSJournal: International researchers among them from @StanfordMed confirmed long-term ... extension of ozanimod trials a favorable safety/tolerability profile & sustained benefit on clinical & #MRI measures of disease activity https://bit.ly/3bRigdH

Click here to > Load More

Discover your ECTRIMS Fellowship

ECTRIMS Newsletter: July 2022

E-Insights: MS and Cognition

Apply for a 2023 ECTRIMS Fellowship

Experience the Evolution: Register for ECTRIMS 2022

Digitally United - Wrapping up ECTRIMS 2021

EAN/ECTRIMS Vaccination Standards for MS patients

ECTRIMS 2021:Be part of an outstanding digital experience 13-15 October 2021

ECTRIMS Focused Workshop 2021 - Highlights

Stay connected

ECTRIMS 2021:
Be part of an outstanding digital experience 13-15 October 2021